A fascinating empirical study of § 101 rejections for *non*-DNA #patents after #Myriad in @NatureBiotech from the @Cambridge_Uni Law, Medicine & Life Sciences group. tl;dr: Myriad is used to invalidate a lot more than gDNA clams. https://t.co/wAcnq7EPEh
An @MIT-led team supporting our Battlefield Medicine program has developed an automated, benchtop, multiproduct manufacturing system for protein biologics. The technology enables rapid, small-scale drug manufacturing for small populations. https://t.co/QBJLFHRgaU
The Defense Department needs small molecules for big missions. DARPA's Accelerated Molecular Discovery program aims to apply #AI-based methods to design, discover & optimize high-performance molecules w/ specific properties. Call for proposals now avail: https://t.co/VRImZ3cbZf.
Want to scale your #digitalhealth startup in the world's largest medical complex? Apply to our upcoming #TMCx accelerator program (https://t.co/FXigL0oGjN), and work with amazing people like @gwynthomas1! Here, she discusses our program with HighDrive TV: https://t.co/2e2shOcbDa
That’s A Wrap: The Bayou Startup Showcase was a SUCCESS this summer!
The Founders and Leadership Team have worked long and hard all summer to make it happen. Class 6 was phenomenal! 🚀
We can’t wait to see you again next year. ⚡️
From health care to media & entertainment, @uhredlabs founders are finding ways to implement technology solutions into startups businesses, which they pitched today at Bayou Startup Showcase. https://t.co/3VIf1Suv9J
Bayou Startup Showcase is THIS THURSDAY! Join us on August 2 at University of Houston for a showcase of the startups from Class 6 from @RiceUniversity’s OwlSpark and RED Labs!
RSVP here: https://t.co/AHwq5vjsIk
#bayoustartupsummer